Your browser doesn't support javascript.
loading
Effect of NPC1L1 polymorphism on warfarin stable dose in Chinese patients under heart valve replacement surgery.
Ma, Siqing; Luo, Zhiying; Zhou, Xinmin; Zhou, Honghao; Chen, Ling; Zhang, Wei.
  • Ma S; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.
  • Luo Z; Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, China.
  • Zhou X; Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, China.
  • Zhou H; National Clinical Research Center for Geriatric Disorders, Changsha, China.
  • Chen L; Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Zhang W; Institute of Clinical Pharmacy, Central South University, Changsha, China.
Clin Exp Pharmacol Physiol ; 49(2): 212-218, 2022 02.
Article en En | MEDLINE | ID: mdl-34606635
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Warfarina / Válvulas Cardíacas Límite: Humans País como asunto: Asia Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Warfarina / Válvulas Cardíacas Límite: Humans País como asunto: Asia Idioma: En Año: 2022 Tipo del documento: Article